Prime Medicine | PRE 14A:并购重组委托声明
04/19 16:10 (美东)
Prime Medicine | 4:持股变动声明-董事 Marrazzo Jeffrey D
03/04 21:21 (美东)
Prime Medicine | S-8:员工福利计划证券登记
03/01 08:14 (美东)
Prime Medicine | 10-K:年度报表
03/01 08:06 (美东)
Prime Medicine | 8-K:重大事件
03/01 08:06 (美东)
Prime Medicine | 3:首次持股声明- GV 2023 GP, L.L.C.
02/29 16:28 (美东)
Prime Medicine | SC 13G/A:超过5%持股股东披露文件(修正)-Alphabet Holdings LLC(12.2%),XXVI Holdings Inc.(12.2%)等
02/29 16:21 (美东)
Prime Medicine | 4:持股变动声明-高管 Gottesdiener Keith Michael
02/27 09:40 (美东)
Prime Medicine | 4:持股变动声明-高管 Goldwasser Meredith
02/23 17:12 (美东)
Prime Medicine | 4:持股变动声明-高管 LEE ANN L.
02/23 17:12 (美东)
Prime Medicine | 4:持股变动声明-高管 Duffield Jeremy
02/23 17:12 (美东)
Prime Medicine | 4:持股变动声明-高管 Brudnick Richard
02/23 17:10 (美东)
Prime Medicine | 4:持股变动声明-高管 Alenson Carman
02/23 17:06 (美东)
Prime Medicine | SC 13D:超过5%持股股东披露文件-ARCH Venture Fund X, L.P.(12.9%),ARCH Venture Fund X Overage, L.P.(12.9%)等
02/22 21:33 (美东)
Prime Medicine | 4:持股变动声明-董事 NELSEN ROBERT
02/20 17:44 (美东)
Prime Medicine | 4:持股变动声明-股东 ARCH Venture Partners XII, LLC
02/20 17:44 (美东)
Prime Medicine | 4:持股变动声明-股东 ARCH Venture Partners X, LLC
02/20 17:40 (美东)
Prime Medicine | 8-K:重大事件
02/16 06:26 (美东)
Prime Medicine | 424B5:募资说明书
02/16 06:21 (美东)
Prime Medicine | FWP:自由书写募资说明书
02/15 06:07 (美东)
暂无数据
暂无数据